Ascelia Pharma AB (OSTO:ACE) 50-Day SMA: kr2.89 (As of Jul. 07, 2026)


OSTO:ACE Ascelia Pharma AB OSTO:ACE
29 GF Score
Price kr0.64
! 1 Warning Sign
View Full Analysis

What is Ascelia Pharma AB 50-Day SMA?

Ascelia Pharma AB OSTO:ACE -20.42% 29 50-Day SMA is kr2.89 as of Jul. 07, 2026. GuruFocus rates OSTO:ACE with a GF Score™ of 29/100. The stock has 1 warning sign investors should review.

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2026-07-07), Ascelia Pharma AB's 50-Day SMA is kr2.89. It's 20-Day SMA is kr2.75 and 200-Day SMA is kr2.98.

Ascelia Pharma AB  (OSTO:ACE) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.

Ascelia Pharma AB 50-Day SMA Related Terms

OSTO:ACE vs VRTX, REGN, ALNY: 50-Day SMA Comparison

For the Biotechnology subindustry, Ascelia Pharma AB's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascelia Pharma AB 50-Day SMA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascelia Pharma AB's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where Ascelia Pharma AB's 50-Day SMA falls into.


OSTO:ACE
29GF Score
Ascelia Pharma AB OSTO:ACE
50-Day SMA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascelia Pharma AB  (OSTO:ACE) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 50-Day SMA →
What does a 50-Day SMA of kr2.89 mean?
Ascelia Pharma AB (OSTO:ACE) has a 50-Day SMA of kr2.89 as of Jul. 07, 2026. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Ascelia Pharma AB and its competitors.
Is Ascelia Pharma AB's 50-Day SMA too high?
Ascelia Pharma AB's current 50-Day SMA is kr2.89. Overall, Ascelia Pharma AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Ascelia Pharma AB's 50-Day SMA compare to VRTX and REGN?
Ascelia Pharma AB's 50-Day SMA of kr2.89 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 50-Day SMA for a Biotechnology company?
A good 50-Day SMA depends on the Biotechnology industry context. However, 50-Day SMA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 50-Day SMA mean?
A high 50-Day SMA can signal that a stock is expensive relative to its fundamentals. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Ascelia Pharma AB and its competitors. Ascelia Pharma AB's current 50-Day SMA is kr2.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascelia Pharma AB stock overvalued right now?
Ascelia Pharma AB (OSTO:ACE) has a current 50-Day SMA of kr2.89. The current 50-Day SMA is kr2.89. Ascelia Pharma AB's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 50-Day SMA calculated?
50-Day SMA is calculated from a company's financial statements. For Ascelia Pharma AB (OSTO:ACE), the current 50-Day SMA is kr2.89 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascelia Pharma AB Business Description

Other Exchanges ACEs:UK
Address Hyllie Boulevard 34, Malmo, SWE, 215 32
Ascelia Pharma AB is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. It has two drug candidates, Orviglance and Oncoral, in development. Orviglance (manganese chloride tetrahydrate) is an oral contrast agent for MR imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with impaired kidney function, and Oncoral is a novel oral irinotecan tablet in development.
29GF Score

Get the complete analysis for OSTO:ACE

50-Day SMA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.64
Price